Circulating HMGB1 promotes dendritic cell maturation and activation via Toll-like receptor 4 (TLR4), which facilitates the cross-presentation of shed tumor antigens by dendritic cells to activate tumor-specific cytotoxic T cells. Here, HMGB1 is linked to neoplasm.